The Salmonella Type III Effector SspH2 Specifically Exploits the NLR Co-chaperone Activity of SGT1 to Subvert Immunity

• Amit P. Bhavsar,

  Affiliations Michael Smith Laboratories, The University of British Columbia, Vancouver, British Columbia, Canada, Department of Medical Genetics, The University of British Columbia, Vancouver, British Columbia, Canada

  ⨯
• Nat F. Brown,

  Affiliations Department of Biochemistry and Molecular Biology, The University of British Columbia, Vancouver, British Columbia, Canada, Centre for High-Throughput Biology, The University of British Columbia, Vancouver, British Columbia, Canada, Department of Microbiology and Immunology, The University of Melbourne, Melbourne, Victoria, Australia

  ⨯
• Jan Stoepel,

  Affiliations Michael Smith Laboratories, The University of British Columbia, Vancouver, British Columbia, Canada, Department of Biochemistry and Molecular Biology, The University of British Columbia, Vancouver, British Columbia, Canada

  ⨯
• Marcel Wiermer,

  Current address: Department of Plant Cell Biology, Georg-August-University Göttingen, Julia-Lermontowa-Weg 337077 Goettingen Germany.

  Affiliation Michael Smith Laboratories, The University of British Columbia, Vancouver, British Columbia, Canada

  ⨯
• Dale D. O. Martin,

  Affiliations Department of Medical Genetics, The University of British Columbia, Vancouver, British Columbia, Canada, Centre for Molecular Medicine and Therapeutics, The University of British Columbia, Vancouver, British Columbia, Canada

  ⨯
• Karolynn J. Hsu,

  Affiliation Michael Smith Laboratories, The University of British Columbia, Vancouver, British Columbia, Canada

  ⨯
• Koshi Imami,

  Affiliation Centre for High-Throughput Biology, The University of British Columbia, Vancouver, British Columbia, Canada

  ⨯
• Colin J. Ross,

  Affiliations Department of Medical Genetics, The University of British Columbia, Vancouver, British Columbia, Canada, Centre for Molecular Medicine and Therapeutics, The University of British Columbia, Vancouver, British Columbia, Canada, Department of Pediatrics, The University of British Columbia, Vancouver, British Columbia, Canada

  ⨯
• Michael R. Hayden,

  Affiliations Department of Medical Genetics, The University of British Columbia, Vancouver, British Columbia, Canada, Centre for Molecular Medicine and Therapeutics, The University of British Columbia, Vancouver, British Columbia, Canada

  ⨯
• Leonard J. Foster,

  Affiliations Michael Smith Laboratories, The University of British Columbia, Vancouver, British Columbia, Canada, Department of Biochemistry and Molecular Biology, The University of British Columbia, Vancouver, British Columbia, Canada, Centre for High-Throughput Biology, The University of British Columbia, Vancouver, British Columbia, Canada

  ⨯
• Xin Li,

  Affiliations Michael Smith Laboratories, The University of British Columbia, Vancouver, British Columbia, Canada, Department of Botany, The University of British Columbia, Vancouver, British Columbia, Canada

  ⨯
• Phil Hieter,

  Affiliations Michael Smith Laboratories, The University of British Columbia, Vancouver, British Columbia, Canada, Department of Medical Genetics, The University of British Columbia, Vancouver, British Columbia, Canada, Department of Biochemistry and Molecular Biology, The University of British Columbia, Vancouver, British Columbia, Canada

  ⨯
• B. Brett Finlay

  * E-mail: bfinlay@msl.ubc.ca

  Affiliations Michael Smith Laboratories, The University of British Columbia, Vancouver, British Columbia, Canada, Department of Biochemistry and Molecular Biology, The University of British Columbia, Vancouver, British Columbia, Canada, Department of Microbiology and Immunology, The University of British Columbia, Vancouver, British Columbia, Canada

  ⨯